What you carry at this position in your DNA and what research says about it.
Metabolic and Heart Health: 5/10 evidence, 58 publications.
You're viewing every possible genotype for this variant.
None of these is your result. Use the genotype toggle to compare them, then sign up and upload your DNA to see which one is yours.
Sample genotype (not yours): C/C
Typical Metabolic and Cardiovascular Risk
Normal G-protein signaling maintains standard cellular communication and baseline metabolic rates. This genotype is associated with a typical risk of high blood pressure and obesity.
What this genotype means: Typical risk of hypertension; Typical risk of obesity; Standard response to sildenafil.
Sample genotype (not yours): C/T
Moderately Elevated Metabolic and Heart Risk
Enhanced G-protein signaling slightly increases cellular sensitivity, which can elevate the risk of high blood pressure and weight gain. Certain medications may also show altered effectiveness.
What this genotype means: Increased risk of high blood pressure; Slightly higher susceptibility to weight gain; Enhanced response to migraine triptans.
Sample genotype (not yours): T/T
Higher Metabolic Risk and Enhanced Drug Response
Hyperactive G-protein signaling increases the risk of obesity and high blood pressure, while significantly enhancing response to erectile dysfunction and migraine medications.
What this genotype means: Elevated risk of obesity and metabolic syndrome; Higher risk of essential hypertension; Significantly better response to sildenafil.
Gene function and biological role
Gene Function: The GNB3 gene encodes the beta 3 subunit of heterotrimeric G-proteins, which are vital components of intracellular signal transduction. These proteins act as molecular messengers, transmitting signals from cell-surface receptors to the interior of cells throughout the body. This signaling pathway regulates diverse physiological processes, including cell growth, blood vessel constriction, and metabolic homeostasis. Variations in this gene can alter how cells respond to hormones, neurotransmitters, and medications. Consequently, GNB3 is heavily implicated in cardiovascular function, fat cell development, and drug response.
Variant Impact: The rs5443 variant, commonly known as C825T, is a synonymous genetic change that alters the splicing of the GNB3 gene. This alternative splicing leads to the production of a truncated G-protein subunit that lacks 41 amino acids. This shortened protein is hyperactive, causing enhanced intracellular signaling and increased cell sensitivity to receptor activation. The resulting hyper-responsiveness affects blood vessel tone, sodium retention in the kidneys, and fat cell differentiation. These cellular changes underlie the variant's association with blood pressure, body weight, and drug efficacy.
Key Insight: The rs5443 variant causes alternative splicing that creates a hyperactive G-protein, which simultaneously increases metabolic risks and dramatically boosts response to certain medications like Viagra.
Location: GNB3. Chromosome 12 · 12p13.31 · 6.8 Mb
Estimated prevalence by population
Global 35.1%; European 48.3%; African 6.9%; East Asian 24.2%; South Asian 46.9%; Americas 35.8%; Ashkenazi 46.8%; Finnish 56.6%; Middle Eastern 24.3%; Amish 43.0%.
Estimated CC genotype frequency.
Global 42.0%; European 42.4%; African 38.7%; East Asian 50.0%; South Asian 43.2%; Americas 48.1%; Ashkenazi 43.2%; Finnish 37.3%; Middle Eastern 50.0%; Amish 45.1%.
Estimated CT genotype frequency.
Global 22.9%; European 9.3%; African 54.4%; East Asian 25.8%; South Asian 10.0%; Americas 16.2%; Ashkenazi 10.0%; Finnish 6.1%; Middle Eastern 25.7%; Amish 11.8%.
Estimated TT genotype frequency.
Showing effects for C/C genotype
Cardiovascular & Metabolic
Obesity & Body Composition
Obesity. Evidence: 4/10. Source: PMID 10477144. Typical Risk.
Hypertension
Hypertension. Evidence: 4/10. Source: PMID 9425898. Typical Risk.
Endocrine & Reproductive
Sexual Function
Sildenafil Response. Evidence: 5/10. Source: PMID 12576843. Typical Response.
Neurology & Mental Health
Headache & Migraine
Headache Drug Response. Evidence: 5/10. Source: PMID 17361120. Typical Response.
Showing effects for C/T genotype
Obesity. Evidence: 4/10. Source: PMID 10477144. Increased Risk.
Hypertension. Evidence: 4/10. Source: PMID 9425898. Increased Risk.
Headache Drug Response. Evidence: 5/10. Source: PMID 17361120. Enhanced Response.
Showing effects for T/T genotype
Obesity. Evidence: 4/10. Source: PMID 10477144. ~2-3x Higher Risk.
Sildenafil Response. Evidence: 5/10. Source: PMID 12576843. Enhanced Response.
What this genotype means for the people who carry it
Sample genotype: CC (Homozygous)
Standard G-protein signaling helps maintain typical blood vessel elasticity and normal sodium balance in the kidneys. Individuals with this genotype generally exhibit a baseline risk for metabolic conditions, including obesity and insulin resistance. Weight loss efforts through lifestyle changes or specific therapies typically follow standard population averages. While cardiovascular risk remains at the population baseline, response to certain medications like beta-blockers may be more pronounced. Standard erectile function treatment response is also typical, with about half of individuals responding to standard doses. Overall, this genotype represents the common, non-elevated baseline for metabolic and heart health.
Typical risk of hypertension; Typical risk of obesity; Standard response to sildenafil.
Sample genotype: CT (Heterozygous)
Increased sensitivity in intracellular signaling pathways can lead to moderate elevations in blood pressure and a higher susceptibility to weight gain. This genotype is associated with a slightly higher likelihood of developing metabolic syndrome and related cardiovascular challenges. Satiety signals in the brain may be subtly altered, potentially influencing appetite and weight management. Response to migraine treatments like triptans is often enhanced, showing a higher rate of positive outcomes. Similarly, blood pressure response to medications like clonidine may be improved compared to the baseline genotype. Managing sodium intake and maintaining active lifestyle habits are particularly beneficial for supporting cardiovascular health with this genetic profile.
Increased risk of high blood pressure; Slightly higher susceptibility to weight gain; Enhanced response to migraine triptans.
Sample genotype: TT (Homozygous)
Hyperactive intracellular signaling leads to increased sodium retention and heightened blood vessel constriction, raising the risk of hypertension. This genotype is strongly linked to a higher susceptibility to obesity and metabolic syndrome across diverse populations. Satiety and metabolic regulation are altered, which can make weight management more challenging and increase weight gain during pregnancy. However, this hyperactive signaling significantly enhances the effectiveness of sildenafil for erectile dysfunction, with over ninety percent of individuals responding positively. Response to migraine treatments like triptans is also substantially improved. Cardiovascular support through a low-sodium diet and regular exercise is highly recommended to mitigate the elevated metabolic risks associated with this genotype.
Elevated risk of obesity and metabolic syndrome; Higher risk of essential hypertension; Significantly better response to sildenafil.
Variants with shared genetic architecture
rs5442 · GNB3 Gene · Chr 12 · Retinal Health and Glaucoma
rs757081 · NUCB2 Gene · Chr 11 · Blood Pressure
rs4149601 · NEDD4L Gene · Chr 18 · Salt-Sensitive Blood Pressure
Content updated August 2026.
ReadYourDNA provides educational interpretation of DNA data you already have. It is not diagnostic, not a substitute for professional medical advice, diagnosis, or treatment, and is not intended to diagnose, treat, cure, or prevent any disease. Talk to a clinician before acting on any result.
Raw DNA Data Reports for 23andMe & AncestryDNA · About ReadYourDNA · FAQ · Methodology & Science · Pricing · Support and complaints · Legal & Contact · Health Traits · Pharmacogenomics · Carrier Status · Variant Explorer · The Human Karyotype · Privacy Policy · Terms of Service · Accessibility · Consumer Health Data Privacy · Your Privacy Choices · Editorial Standards · Your Data, Checkable · Sample Report · ReadYourDNA and Promethease compared · What is inside a 23andMe raw data file · What is inside an AncestryDNA raw data file · What a chatbot can and cannot do with your raw DNA file · Where a raw DNA file can still be uploaded in 2026
Written, maintained and operated by Martin Pechhacker, sole proprietor, Vienna, Austria. Trade register GISA 40064420. support@readyourdna.com